1. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Issue 8 (9th February 2006) Authors: Russell, R K; Drummond, H E; Nimmo, E R; Anderson, N H; Noble, C L; Wilson, D C; Gillett, P M; McGrogan, P; Hassan, K; Weaver, L T; Bisset, W M; Mahdi, G; Satsangi, J Journal: Gut Issue: Volume 55:Issue 8(2006) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-TNF-α therapy for orofacial granulomatosis: proceed with caution. Issue 10 (11th September 2006) Authors: Gaya, D R; Aitken, S; Fennell, J; Satsangi, J; Shand, A G Journal: Gut Issue: Volume 55:Issue 10(2006) Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AODTH-006 Hypermutation and mutational signatures in inflammatory bowel disease-associated colorectal cancers. (17th June 2017) Authors: Din, S; Wong, K; Mueller, MF; Oniscu, A; James, H; Black, CJ; Miller, ML; Jiménez-Sánchez, A; Rabbie, R; Rashid, M; Satsangi, J; Adams, DJ; Arends, MJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AODTH-008 Proximity extension assay based proteins show immune cell specificity and can diagnose and predict outcomes in inflammatory bowel diseases: ibd character study. (17th June 2017) Authors: Kalla, R; Adams, AT; Vatn, S; Bergemalm, D; Ricanek, P; Lindstrom, JC; Ocklind, A; Nordberg, N; Kennedy, NA; Ventham, N; Vatn, MH; Soderholm, JD; Pierik, M; Torkvist, L; Gomollon, F; Jahnsen, J; Halfvarson, J; Satsangi, J; Consortium, IBD Character Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AODWE-007 Real world data on the effectiveness and safety of vedolizumab in the treatment of crohn's disease and ulcerative colitis: the edinburgh experience. (17th June 2017) Authors: Plevris, N; Manship, TA; Deekae, A; Jones, GR; Noble, CL; Satsangi, J; Shand, AG; Arnott, ID; Lees, CW Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical and genetic factors predict severe disease: a novel composite severity index. (13th March 2011) Authors: Phillips, A; Arnott, I; Heron, T; Cleary, S; Mowat, C; Clark, H; Lewin-Koh, N; Satsangi, J Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical patterns of familial inflammatory bowel disease. Issue 5 (May 1996) Authors: Satsangi, J; Grootscholten, C; Holt, H; Jewell, D P Journal: Gut Issue: Volume 38:Issue 5(1996) Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Crohn's disease or Crohn's diseases?. Issue 4 (1st April 2003) Authors: Arnott, I D R; Satsangi, J Journal: Gut Issue: Volume 52:Issue 4(2003) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cytokine gene polymorphisms in inflammatory bowel disease. Issue 5 (November 1996) Authors: Louis, E; Satsangi, J; Roussomoustakaki, M; Parkes, M; Fanning, G; Welsh, K; Jewell, D Journal: Gut Issue: Volume 39:Issue 5(1996) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cytokine production in inflammatory bowel disease. Issue 5 (May 1994) Authors: Satsangi, J; Jewell, D P Journal: Gut Issue: Volume 35:Issue 5(1994) Page Start: 714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗